Clinical Trial Update: An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial compared safety and efficacy of VIGAMOX (moxifloxacin ophthalmic solution 0.5%) versus Ofloxacin ophthalmic solution 0.3% in Chinese patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• Ofloxacin ophthalmic solution (ofloxacin)
• VIGAMOX (Moxifloxacin hydrochloride)

Snippet

Sponsor: Alcon Research | Conditions: Bacterial Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2015-05-12